|
Oct 10
|
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
|
|
Jul 31
|
Immutep Quarterly Activities Report Q4 FY24
|
|
Apr 24
|
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
|
|
Apr 24
|
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
|
|
Feb 5
|
10 Best Australian Stocks To Buy
|
|
Dec 21
|
Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
|
|
Dec 7
|
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
|
|
Nov 27
|
Immutep (ASX:IMM) investors are sitting on a loss of 22% if they invested five years ago
|
|
Apr 27
|
Immutep Quarterly Activities Report
|
|
Apr 26
|
Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
|
|
Apr 26
|
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
|